Dr. Terjanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
256C Mason Avenue
Staten Island, NY 10305Phone+1 718-226-6400Fax+1 718-226-6404
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1987 - 1988
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1984 - 1986
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 1981 - 1984
- St Joseph's University Medical SchoolClass of 1978, MD
Certifications & Licensure
- NY State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2010-2014
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Publications & Presentations
PubMed
- Metastatic Fibrosarcomatous Transformation of Dermatofibrosarcoma Protuberans With Lung Metastasis: A Case Report.Salman Khan, Ekrem Yetiskul, Muhammad Niazi, Malik Waleed Zeb Khan, Ngowari Pokima
Cureus. 2024-05-01 - 1 citationsCOVID-Induced Thrombotic Thrombocytopenic Purpura: A Case Report and Treatment-Focused Review.Madeeha Subhan Waleed, Lohitha Dhulipalla, Muhammad Niazi, Terenig Terjanian, Meekoo Dhar
Cureus. 2024-03-01 - 5 citationsA Meta-Analysis of Randomized Clinical Trials Assessing the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer.Zakaria Alameddine, Muhammad Rafay Khan Niazi, Anisha Rajavel, Jai Behgal, Praneeth Reddy Keesari
Current Oncology. 2023-10-19
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Armenian, French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: